ep miss cordi conundrum guid cut
ep consensu adj ep
fell short estim slightli better revenu
profit factor line neg impact ep
cut ep guidanc reflect miss tax estimate
well materi slower growth cordi lower
ep estim cut tp
meaning lower expect
revenu profit slightli plan revenu
stronger core growth vs estimate
profit growth pharma well ahead plan partial off-set
notabl weaker medic profit growth reflect pr
acquisit off-set cordis/lik exam glove challeng ebit
margin fell bp slightli bp plan gener
million cash facilit mln buyback mln dividend
share slide expect undoubtedli low latest
report wors fear meaning lower outlook
medic segment increment associ tax headwind expos
prolong profit challeng diversif strategi said
maintain consolid revenu growth outlook msd
profit target core pharma segment modestli improv -hsd-ldd
prior -ldd better red oak contribut partial off-set less
favor gener deflat outlook m-hsd msd medic clearli
remain challeng core segment profit target declin high-teen
vs prior flat-down cordi focu call abil
address medic woes/execut recent acquisit remain
posit dispos stock patienc challeng degre
latest shortfal risk drug price acquisit miscu
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
healthcar servic product compani
distribut brand gener pharmaceut well broad
varieti medic surgic product
price may rate outperform target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
cash-flow financ activ
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
better fundament perform sentiment could drive upsid
target price blue sky scenario
weaker fundament perform sentiment could lead
downsid versu target price grey sky scenario
 close
million
charl martineau pm univers toronto compani mention price
